These emerging therapies , Tirzepatide , represent a remarkable advancement in treating type 2 diabetes and possibly other disorders. These drugs are categorized as GLP-1 pathway stimulators, indicating they function to emulate the endogenous GLP-1 peptide, boosting metabolic production and suppressing hunger . Despite Tirzepatide each functions re